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Background: Appropriate use criteria (AUC) have been developed by professional organizations as a response to
the rising costs of imaging, with the goal of optimizing test-patient selection. Consequently, the AUC are now
increasingly used by third-party-payers to assess reimbursement. However, these criteria were created by expert
consensus and have not been systematically assessed for CMR. The aim of this study was to determine the rates of
abnormal stress-CMR and subsequent downstream utilization of angiography and revascularization procedures
based on the most recent AUC.
Methods: 300 consecutive patients referred for CMR-stress testing were prospectively enrolled. Two cardiologists
reviewed all clinical information before the CMR-stress test and classified the test as “appropriate’, “maybe appropriate”
or “rarely appropriate” according to the 2013 AUC. Patients were followed for 2 months for the primary outcomes of
coronary angiography and/or revascularization.
Results: 49.7% of stress CMRs were appropriate, 36.7% maybe appropriate, and 13.6% rarely appropriate. Ischemia was
significantly more likely to be seen in the appropriate (18.8%) or maybe appropriate groups (21.8%) than the rarely
appropriate group (4.8%) (p = 0.030 and p = 0.014 respectively). Referral for cardiac catheterization was not significantly
different in the appropriate (10.1%) and maybe appropriate groups (10.0%) compared to the rarely appropriate group
(2.4%) (p = 0.119 and p = 0.127 respectively). No patients undergoing catheterization in the rarely appropriate group
went on to require revascularization, in contrast to 53.3% of the appropriate vs 36.4% of the maybe appropriate
patients (p = 0.391). Presence of ischemia led to referral for cardiac catheterization in 50.0% of the appropriate group vs
33.3% of the maybe appropriate group (p = 0.225); in contrast to none of the rarely appropriate group.
Conclusions: The great majority of tests were classified as appropriate or maybe appropriate. Downstream cardiac
catheterization rates were similar in all 3 groups. However, rarely appropriate studies never required revascularization,
suggesting suboptimal resource utilization. Studies classified as maybe appropriate had similar rates of abnormal
findings and led to similar rates of downstream catheterization and revascularization as those that were deemed
appropriate. This suggests that consideration could be given to upgrading some of the common maybe appropriate
indications to the appropriate category.* Correspondence: afshin@uic.edu
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As a response to fiscal pressures and with the goal of opti-
mizing test-patient selection, appropriate use criteria
(AUC) have been developed by several professional orga-
nizations - including the American College of Cardiology,
the Society for Cardiovascular Magnetic Resonance, the
American Society of Nuclear Cardiology and the
American Society of Echocardiography [1–5]. Conse-
quently, the AUC are now increasingly used by payers
to assess the suitability of reimbursement for imaging
procedures. Moreover, recent approval of the “Protect-
ing Access to Medicare Act” (PAMA) by the United
States Congress has very significant implications for the
application of AUC to CMR reimbursement [6,7]. It
states that starting in 2017 - in order to be paid by
Medicare for advanced imaging - certification must be
provided that the ordering physicians consulted the
AUC. The claim to Medicare must specify whether the
requested imaging adheres to the AUC. The act also
states that criteria must be developed by national med-
ical societies or provider-led entities and should be evi-
dence based, to the extent possible. By November 2015,
the Centers for Medicare and Medicaid Services (CMS)
must select the specific AUC to be used. Finally, in
2020 CMS must identify up to 5% of physicians as out-
liers in adherence to AUC, who may then be subject to
prior authorization.
Stress CMR is increasing used in the management of
patients with known or suspected coronary artery dis-
ease [8]. The initial AUC for stress CMR was recently
replaced by the AUC for stable ischemic heart disease,
as part of a new multimodality approach [1,5]. The AUC
were developed by a panel who were asked to rate 80
clinical indications as being “appropriate”, “maybe ap-
propriate”, or “rarely appropriate”. However, these cri-
teria were created by expert consensus and have never
been systematically assessed or validated for CMR. In
particular, there is no data regarding the impact of the
AUC on downstream cardiac procedures.
The aims of this study were to determine the rates of
abnormal stress CMR results and subsequent down-
stream utilization of angiography and revascularization
procedures based on the most recent AUC.
Methods
Study population
Three hundred consecutive patients referred for CMR
stress testing were prospectively enrolled in a single aca-
demic medical center. Patients were excluded if they had
metallic implants incompatible with CMR, glomerular fil-
tration rate < 30 ml/min, high degree atrio-ventricular
block, severe active wheezing from asthma or severe claus-
trophobia. Subjects were asked to abstain from caffeine-
containing products for at least 12 h prior to the test.Clinical variables
Demographic and clinical characteristics were recorded
prospectively at the time of CMR stress testing from pa-
tient interviews and the electronic medical record. Pa-
tients gave informed written consent for the protocol,
which was approved by the local institutional review
board.
CMR acquisition
Images were acquired on a 3 T scanner (Philips Achieva,
Philips Medical Systems, Best, the Netherlands) using a
six-element phased-array receiver coil as previously de-
scribed [9]. Steady-state free-precession cine images
were acquired in multiple short-axis and three long-axis
views (repetition time, 3.0 ms; echo time, 1.5 ms; flip
angle, 40°; slice thickness 6 mm).
The patient table was then partially pulled outside the
scanner bore to allow direct observation of the patient
and full access. A 0.4 mg bolus of regadenoson (Lexiscan,
Astellas Pharma Inc) was infused under continuous
electrocardiography and blood pressure monitoring.
Approximately 1 min after regadenoson administration,
the perfusion sequence was applied and Gadolinium
contrast (0.075 mmol/kg gadoteridol, Bracco Diagnos-
tics) followed by a saline flush (30 ml) was infused
(4.5 ml/s) via an antecubital vein. On the console, the
perfusion images were observed as they were acquired,
with breath-holding starting from the appearance of
contrast in the right ventricular cavity. Imaging was
completed 10 to 15 s after the gadolinium bolus had
transited the left ventricular myocardium. Perfusion im-
ages consisted of three to four short-axis slices obtained
every heartbeat with a saturation-recovery, gradient-
echo sequence (repetition time 2.8 ms; echo time
1.1 ms; flip angle 20°; voxel size, 2.5 × 2.5 × 8 mm). Am-
inophylline (100 mg IV) was administered immediately
after stress perfusion imaging [9]. Rest perfusion images
were acquired 15 min after stress imaging with an add-
itional contrast bolus (0.075 mmol/kg gadoteridol)
using identical sequence parameters. Five minutes after
rest perfusion, late gadolinium enhancement (LGE) im-
aging was performed with a 2D segmented gradient
echo phase-sensitive inversion-recovery sequence in the
identical views as cine-CMR. Inversion delay times
were typically 280 to 360 ms. Perfusion and LGE im-
ages were visually interpreted by standard methods
[10]. The pattern of LGE was classified as either infarct
or non-CAD type on the basis of subendocardial en-
hancement [11,12].
Patient classification for AUC
Two independent general cardiologists reviewed all clin-
ical information dated before the CMR stress test. These
reviewers were blinded to the results of the CMR and to
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stress tests were classified as “appropriate’, “maybe ap-
propriate” or “rarely appropriate” as defined by the 2013
AUC [5]. A third blinded independent physician adjudi-
cated any discrepancy between the interpreters.Follow-up
After CMR, patients were prospectively followed for
2 months for the primary outcomes of coronary angiog-
raphy and/or revascularization. Clinical follow-up was
based on review of the electronic medical records or from
telephone interviews with patients or their physicians.Statistical analysis
Normally distributed data were expressed as mean ± SD.
Continuous variables were compared by the Student’s
t-test or Wilcoxon rank-sum (depending on data nor-
mality). Comparisons of discrete variables were made
using the chi-square test; Fisher’s exact test was used
when the assumptions of the chi-square test were not
met. A p value of <0.05 was considered statistically
significant.Results
Patient characteristics
Table 1 summarizes the baseline patient characteristics.
The mean age of the study population was 59 years. 54%
of patients were female and 36% had diabetes mellitus.
32% had known coronary artery disease, including prior
PCI (17%) and CABG (4%). The mean ejection fraction
was 61%. Of the 300 CMRs reviewed, arbitration for
AUC assignment by a third cardiologist was required for
just 1 patient.Table 1 Baseline Characteristics Stratified by Appropriate Use
CHARACTERISTICS Total N = 300 Appropriate N = 149 M
Age (±SD) 59 (±13.6) 61 (±12.0) 6
Female % 54.0 49.7
BMI (±SD) 30.8 (±5.7) 31.3 (±5.4) 3
Diabetes % 36.2 43.6
Hyperlipidemia % 53.6 60.4
Current Smoking % 16.3 18.8
Hypertension % 73.0 78.5
Known CAD % 32.1 39.6
Prior MI % 13.6 16.1
Prior PCI % 16.9 22.8
Prior CABG % 4.3 3.4
LVEF (±SD) 61 (±10.9) 60.3 (±12.0) 6
BMI, Body Mass Index; CAD, Coronary Artery Disease; LVEF, Left Ventricular Ejection
CABG, Coronary Artery Bypass Grafting; SD, standard deviationPrimary outcomes
At 2 months of follow-up, the endpoint of coronary
angiography occurred in 27 patients and the endpoint of
revascularization occurred in 12 patients (PCI = 11,
CABG = 1).
Appropriateness
Based on the 2013 AUC, 49.7% of stress CMRs were
classified as appropriate, 36.7% as maybe appropriate,
and 13.6% as rarely appropriate. A comparison of the
baseline characteristics across AUC is given in Table 1.
There were significant differences in age, prevalence of
diabetes, hyperlipidemia, smoking, hypertension, and
known CAD across the three groups.
The six most frequent AUC categories accounted for
179 patients (Table 2). Of patients with these common
six indications approximately 69% were classified as ap-
propriate and 31% as maybe appropriate.
Relationship of appropriateness to CMR results
Abnormal CMR stress results (defined as presence of
ischemia or scar) were more common in the appropri-
ate (29.5%) and maybe appropriate (28.2%) groups
compared with the rarely appropriate (14.6%) group al-
though the differences did not reach statistical signifi-
cance (p = 0.055 and p = 0.085 respectively) (Fig. 1).
Ischemia was significantly more likely to be seen in pa-
tients in the appropriate (18.8%) or maybe appropriate
groups (21.8%) than the rarely appropriate group (4.8%)
(p = 0.030 and p = 0.014 respectively) (Fig. 2).
Relationship of appropriateness to downstream
angiography and revascularization
There was a trend towards more referral for cardiac
catheterization in the appropriate (10.1%) and maybeCriteria
aybe Appropriate N = 110 Rarely Appropriate N = 41 P Value
1 (±13.3) 46 (±14.4) <0.0001
55.0 66.7 0.1703









1 (±10.7) 62 (±6.8) 0.4800
Fraction; MI, myocardial infarction; PCI, Percutaneous Coronary Intervention;
Table 2 AUC categories in our study population
AUC Description N Classification
Follow-up testing (>90 days) for new or worsening symptoms with non-obstructive CAD on coronary angiography (invasive or
noninvasive) OR normal prior stress imaging study
48 A
Symptomatic in intermediate pre-test probability of CAD with interpretable ECG AND able to exercise 32 M
Symptomatic in intermediate pre-test probability of CAD with uninterpretable ECG OR unable to exercise 27 A
Newly diagnosed systolic heart failure (resting LV function previously assessed but no prior CAD evaluation) 25 A
Evaluation for symptomatic (ischemic equivalent) post-revascularization (PCI or CABG) 24 A
Sequential or follow up testing (≤90 days) with uncertain results on prior stress imaging study (not stress CMR) where obstructive
CAD remains a concern
23 M
Symptomatic in low pre-test probability of CAD with interpretable ECG AND able to exercise 20 R
Pre-operative clearance in poor or unknown functional capacity (<4 METS); intermediate risk surgery with ≥1 clinical risk factor 12 M
High pre-test probability of CAD with an interpretable ECG and able to exercise 8 A
High pre-test probability of CAD with an uninterpretable ECG and unable to exercise 6 A
Follow up testing for new or worsening symptoms with an abnormal prior stress imaging study 6 M
Follow up testing (>90 Days) in an asymptomatic or symptomatically stable patient whose last study was≥ 2 years ago 4 M
Follow up testing (>90 Days) in an asymptomatic patient without ischemic equivalent, who has a normal prior stress imaging
study or non-obstructive CAD on angiogram who is intermediate to high global CAD risk with a study≥ 2 years ago
4 M
Follow up testing (>90 Days) in an a patient with stable symptoms, who has a normal prior stress imaging study or non-obstructive
CAD on angiogram who is intermediate to high global CAD risk with a study≥ 2 years ago
4 M
Symptomatic patients who are low pre-test probability of CAD with an uninterpretable ECG or unable to exercise 3 M
Newly diagnosed diastolic heart failure 3 A
Evaluation of arrhythmias without ischemic equivalent with frequent PVCs 3 M
Syncope without ischemic equivalent in a patient with low global CAD risk 3 R
Follow up testing (>90 Days) in an asymptomatic or symptomatically stable patient with a history of abnormal prior stress imaging
study < 2 years ago
3 R
Follow up testing (>90 Days) in an asymptomatic patient with a normal prior stress imaging study OR non-obstructive CAD on
angiogram
3 R
Follow up testing for new or worsening symptoms in a patient with prior obstructive CAD on invasive coronary angiography 3 M
Pre-op risk stratification in a patient with poor or unknown functional capacity (<4 METs) in a patient who is undergoing vascular
surgery with ≥ 1 clinical risk factor
3 M
AUC, Appropriate Use Criteria; A, Appropriate, M, Maybe Appropriate; R, Rarely Appropriate; CAD, Coronary Artery Disease; ECG, Electrocardiogram; LV, Left Ventricular;
PCI, Percutaneous Coronary Intervention; CABG, Coronary Artery Bypass Grafting; PVC, Premature Ventricular Beat
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priate group (2.4%), but the differences were not statisti-
cally significant (p = 0.119 and p = 0.127 respectively).
However, none of the patients undergoing catheterization
in the rarely appropriate group went on to require revas-
cularization, in contrast to 53.3% of the appropriate vs
36.4% of the maybe appropriate patients (p = 0.391)
(Fig. 3).
Relationship of abnormal CMR results with referral to
downstream angiography
The finding of ischemia on CMR led to referral for car-
diac catheterization in 50.0% of the appropriate group
vs 33.3% of the maybe appropriate group (p = 0.225).
In contrast none of the rarely appropriate patients with
ischemia were referred for cardiac catheterization.
Based on an angiographic cut-off of ≤50% major epi-
cardial stenosis, stress-CMR had a sensitivity = 94%,specificity = 44%, positive predictive value = 77%, and
negative predictive value = 80%, in this biased referral
population.
Discussion
Due to rising healthcare costs, appropriate use of cardio-
vascular imaging is increasingly emphasized by profes-
sional societies, third party payers and accreditation
agencies [6,7,13,14]. To the best of our knowledge this is
the first study to systematically and prospectively assess
the downstream utilization of angiography and revascu-
larization procedures based on the AUC for stress-CMR.
We have shown that tests categorized by the AUC as
rarely appropriate, infrequently demonstrate ischemia,
but the rates of downstream cardiac catheterization were
not significantly different to those categorized as appro-
priate or maybe appropriate. Importantly when patients
underwent cardiac catheterization none of the rarely
Fig. 1 Appropriate use criteria and stress-CMR findings in the study population
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cularization. These findings appear to support the
current AUC classification of rarely appropriate stress-
CMR studies, since this group appears to result in sub-
optimal resource utilization.Fig. 2 Studies with ischemia categorized by appropriate use criteriaIn our study population, the great majority of tests or-
dered were deemed as appropriate or maybe appropriate.
Only, approximately 14% of the stress-CMRs were catego-
rized as rarely appropriate. This is similar to the inappro-
priate proportions reported for stress echocardiography
Fig. 3 Patients undergoing cardiac catheterization who required revascularization, categorized by appropriate use criteria
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Tomography (SPECT) (7–46%) [17–19], and Positron
Emission Tomography (PET) (10.2%) [20]. It is interest-
ing to speculate whether growing pre-certification de-
mands by third-party payers may have affected
physicians test orderings patterns, but this cannot be
assessed from this study.
We found that studies that were classified as maybe
appropriate had similar rates of ischemia and led to
similar rates of downstream catheterization and revascu-
larization as those that were deemed appropriate. This
suggests that consideration could be given to upgrading
some of the common maybe appropriate indications to
the appropriate category (Table 2).
It is interesting to note that even when ischemia was
reported, patients were more likely to be referred for
cardiac catheterization in the appropriate and maybe ap-
propriate groups. In fact none of the patients with ische-
mia in the rarely appropriate group were referred for
cardiac catheterization. The reasons for this are unclear
but may relate to physician’s assessment that invasive
testing and revascularization would not significantly
change outcomes or symptoms in this patient group.
In this study we have looked at the rates of abnormal
stress tests and the endpoints of downstream angiog-
raphy and revascularization to help assess optimal test-
patient selection and imaging utilization. However, there
are a number of important caveats to bear in mind.
Higher rates of abnormal findings and greater use of
angiography or revascularization doesn’t necessarily
imply better outcomes. Such validation would require
performance of prospective randomized outcome trials.
Ideally these studies should be part of larger initiatives
to compare the effectiveness of different imaging modal-
ities. Although, such studies will be challenging toperform and fund, they are of critical importance in
clarifying optimal imaging strategies. Another important
point to emphasize is that stress testing can be very use-
ful in patient management even when it does not lead to
angiography or revascularization [21]. For example a
normal study may lead to exclusion of coronary artery
disease as a cause of symptoms, as well as to clinic/
hospital discharge; or it may lead to ‘surgical clearance’
in patients referred prior to elective non-cardiac surgery.
Further studies are required to more comprehensively
assess these types of clinical impact and management
change [22,23].
Future steps in assessing and validating AUC for
stress-CMR should aim to compare the prognostic abil-
ity of the test across the various AUC categories. Such
an approach was recently undertaken by Doukky et al.
in a large nuclear study [19]. They demonstrated that in-
appropriate use of SPECT was associated with reduced
prognostic value. In those patients whose scans were ap-
propriate or uncertain, abnormal scans were of signifi-
cant value in predicting major adverse cardiac events
(hazard ratio 3.1–3.7) compared with normal scans.
However, in those with inappropriate scans, abnormal
studies did not achieve significance in predicting adverse
cardiac events. Moreover, all abnormal SPECT findings
were associated with increasing rates of revasculariza-
tion, irrespective of the level of appropriateness.
Limitations
Our study was limited by a small sample size (n = 300)
drawn from a single academic institution and may not
be representative of the wider population. However, this
may have the advantage of providing uniform scanning,
interpretation and follow-up protocols. Larger studies with
greater statistical power and more events (particularly
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lysis of subgroups. The results of this study should there-
fore be regarded as preliminary, until larger multicenter
studies are completed. As mentioned above, cardiac
catheterization and revascularization are only part of the
downstream clinical consequences of CMR-stress. Cost-
effectiveness was not assessed in this study and clearly
needs to be the subject of future studies aiming to establish
the validity of the AUC.
Conclusions
The great majority of tests ordered in our population
were classified as appropriate or maybe appropriate.
Downstream referral for cardiac catheterization was not
significantly different in the 3 groups. However, rarely
appropriate studies never required revascularization,
suggesting suboptimal resource utilization. Studies clas-
sified as maybe appropriate had similar rates of abnor-
mal findings and led to similar rates of downstream
catheterization and revascularization as those that were
deemed appropriate. This suggests that consideration
could be given to upgrading some of the common maybe
appropriate indications to the appropriate category.
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